chr1-161749826-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_007240.3(DUSP12):c.25G>A(p.Asp9Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000012 in 1,587,898 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_007240.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DUSP12 | NM_007240.3 | c.25G>A | p.Asp9Asn | missense_variant | 1/6 | ENST00000367943.5 | |
DUSP12 | XM_005244862.4 | c.-379G>A | 5_prime_UTR_variant | 1/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DUSP12 | ENST00000367943.5 | c.25G>A | p.Asp9Asn | missense_variant | 1/6 | 1 | NM_007240.3 | P1 | |
ATF6-DT | ENST00000702792.1 | n.914C>T | non_coding_transcript_exon_variant | 3/3 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152248Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000976 AC: 2AN: 204910Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 111436
GnomAD4 exome AF: 0.00000488 AC: 7AN: 1435650Hom.: 0 Cov.: 31 AF XY: 0.00000421 AC XY: 3AN XY: 712182
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152248Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74384
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 21, 2021 | The c.25G>A (p.D9N) alteration is located in exon 1 (coding exon 1) of the DUSP12 gene. This alteration results from a G to A substitution at nucleotide position 25, causing the aspartic acid (D) at amino acid position 9 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at